MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 31, 2005; DOI: 10.1124/mol.105.011007


0026-895X/05/6705-1751-1757$20.00
Mol Pharmacol 67:1751-1757, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.011007v1
67/5/1751    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feißt, C.
Right arrow Articles by Werz, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feißt, C.
Right arrow Articles by Werz, O.
ORIGINAL ARTICLE

The Aminosteroid Phospholipase C Antagonist U-73122 (1-[6-[[17-{beta}-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) Potently Inhibits Human 5-Lipoxygenase in Vivo and in Vitro

Christian Feißt, Dana Albert, Dieter Steinhilber, and Oliver Werz

Institute of Pharmaceutical Chemistry, University of Frankfurt, Frankfurt, Germany

Abstract

U-73122 (1-[6-[[17-{beta}-3-methoxyestra-1,3,5(10)-trien-17-yl]amino] hexyl]-1H-pyrrole-2,5-dione) is a widely used antagonist of phosphoinositide-specific phospholipase C (PLC) and is frequently used to define a role of PLC in receptor-mediated elevation of intracellular calcium concentration ([Ca2+]i). In human polymorphonuclear leukocytes (PMNLs), U-73122 inhibited increases in [Ca2+]i induced by G protein-coupled receptor (GPCR) agonists (N-formyl-methionyl-leucyl-phenylalanine or platelet-activating factor; IC50 of {approx}2 to 4 µM), but it failed to suppress responses induced by ionomycin or thapsigargin. 5-Lipoxygenase (5-LO) is a Ca2+-regulated enzyme that can be activated in leukocytes by stimuli that elevate [Ca2+]i. Attempts to investigate the involvement of PLC in cellular 5-LO activation revealed that U-73122 suppresses 5-LO product synthesis regardless of the stimulus and independently of Ca2+. Thus, U-73122 blocked 5-LO product synthesis induced by cell stress, involving 5-LO phosphorylation pathways in the absence of Ca2+ with an IC50 of {approx}2 µM. Direct inhibition of 5-LO by U-73122 was evident in PMNL homogenates (IC50 of {approx}2.4 µM), and isolated human recombinant 5-LO enzyme was potently inhibited by U-73122 (IC50 of {approx}30 nM). Thiols (glutathione) strongly blunted the effect of U-73122 on isolated 5-LO. On the other hand, depletion of cellular thiols by N-ethylmaleimide strongly increased the efficacy of U-73122 to inhibit 5-LO in intact cells or corresponding homogenates, suggesting that U-73122 may interfere with sulfhydryl groups on 5-LO. Since 5-LO products induce increases in [Ca2+]i via GPCRs, caution should be used when interpreting data where U-73122 is used as tool to determine a direct role of PLC in receptor-mediated Ca2+ mobilization.


Received January 6, 2005; accepted January 31, 2005

Address correspondence to: Dr. Oliver Werz, Institute of Pharmaceutical Chemistry, University of Frankfurt, Marie-Curie Strasse 9, D-60439 Frankfurt, Germany. E-mail: o.werz{at}pharmchem.uni-frankfurt.de




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E. A. Woodcock, P. M. Kistler, and Y. Ju
Phosphoinositide signalling and cardiac arrhythmias
Cardiovasc Res, November 11, 2008; (2008) cvn283v2.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-i. Otsuguro, J. Tang, Y. Tang, R. Xiao, M. Freichel, V. Tsvilovskyy, S. Ito, V. Flockerzi, M. X. Zhu, and A. V. Zholos
Isoform-specific Inhibition of TRPC4 Channel by Phosphatidylinositol 4,5-Bisphosphate
J. Biol. Chem., April 11, 2008; 283(15): 10026 - 10036.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Albert, C. Pergola, A. Koeberle, G. Dodt, D. Steinhilber, and O. Werz
The role of diacylglyceride generation by phospholipase D and phosphatidic acid phosphatase in the activation of 5-lipoxygenase in polymorphonuclear leukocytes
J. Leukoc. Biol., April 1, 2008; 83(4): 1019 - 1027.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
N. E. Wilsher, W. J. Court, R. Ruddle, Y. M. Newbatt, W. Aherne, P. W. Sheldrake, N. P. Jones, M. Katan, S. A. Eccles, and F. I. Raynaud
The Phosphoinositide-Specific Phospholipase C Inhibitor U73122 (1-(6-((17{beta}-3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione) Spontaneously Forms Conjugates with Common Components of Cell Culture Medium
Drug Metab. Dispos., July 1, 2007; 35(7): 1017 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
D. Helling, A. Possart, S. Cottier, U. Klahre, and B. Kost
Pollen Tube Tip Growth Depends on Plasma Membrane Polarization Mediated by Tobacco PLC3 Activity and Endocytic Membrane Recycling
PLANT CELL, December 1, 2006; 18(12): 3519 - 3534.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Poeckel, L. Tausch, S. George, J. Jauch, and O. Werz
3-O-Acetyl-11-keto-boswellic Acid Decreases Basal Intracellular Ca2+ Levels and Inhibits Agonist-Induced Ca2+ Mobilization and Mitogen-Activated Protein Kinase Activation in Human Monocytic Cells
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 224 - 232.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics